Increasing patient participation in oncology clinical trials.
Cancer Med
; 2022 Aug 31.
Article
in English
| MEDLINE | ID: covidwho-2313589
ABSTRACT
AIM:
Timely recruitment of eligible participants is essential for the success of clinical trials, with insufficient accrual being the leading cause for premature termination of both oncology and non-oncology trials.METHODS:
In this paper we further elaborate on the challenges for patient participation in oncology trials from physician, patient, healthcare system, and some trial-related perspectives.RESULTS:
We present strategies such as use of digital healthcare technologies, real-world data and real-world evidence, decentralized clinical trials, pragmatic trial designs, and supportive services to increase patient participation.CONCLUSIONS:
Multifaceted measures are necessary to increase patient participation, especially for those who are under-represented in cancer trials.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Prognostic study
/
Randomized controlled trials
Language:
English
Year:
2022
Document Type:
Article
Affiliation country:
Cam4.5150
Similar
MEDLINE
...
LILACS
LIS